Stock Research for APHB

APHB

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

APHB Stock Chart & Research Data

The APHB chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the APHB chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


APHB Due diligence Resources & Stock Charts

The APHB stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View APHB Detailed Price Forecast - CNN Money CNN View APHB Detailed Summary - Google Finance
Yahoo View APHB Detailed Summary - Yahoo! Finance Zacks View APHB Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View APHB Trends & Analysis - Trade-Ideas Barrons View APHB Major Holders - Barrons
NASDAQ View APHB Call Transcripts - NASDAQ Seeking View APHB Breaking News & Analysis - Seeking Alpha
Spotlight View APHB Annual Report - CompanySpotlight.com OTC Report View APHB OTC Short Report - OTCShortReport.com
TradeKing View APHB Fundamentals - TradeKing Charts View APHB SEC Filings - Bar Chart
WSJ View Historical Prices for APHB - The WSJ Morningstar View Performance/Total Return for APHB - Morningstar
MarketWatch View the Analyst Estimates for APHB - MarketWatch CNBC View the Earnings History for APHB - CNBC
StockMarketWatch View the APHB Earnings - StockMarketWatch MacroAxis View APHB Buy or Sell Recommendations - MacroAxis
Bullish View the APHB Bullish Patterns - American Bulls Short Pains View APHB Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View APHB Stock Mentions - StockTwits PennyStocks View APHB Stock Mentions - PennyStockTweets
Twitter View APHB Stock Mentions - Twitter Invest Hub View APHB Investment Forum News - Investor Hub
Yahoo View APHB Stock Mentions - Yahoo! Message Board Seeking Alpha View APHB Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for APHB - SECform4.com Insider Cow View Insider Transactions for APHB - Insider Cow
CNBC View APHB Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for APHB - OTC Markets
Yahoo View Insider Transactions for APHB - Yahoo! Finance NASDAQ View Institutional Holdings for APHB - NASDAQ


Stock Charts

FinViz View APHB Stock Insight & Charts - FinViz.com StockCharts View APHB Investment Charts - StockCharts.com
BarChart View APHB Stock Overview & Charts - BarChart Trading View View APHB User Generated Charts - Trading View




Latest Financial News for APHB


AmpliPhi Biosciences Announces Positive FDA Feedback for its Clinical Stage Bacteriophage Product Candidate AB-PA01 Targeting Pseudomonas Aeruginosa Infections
Posted on Tuesday September 18, 2018

AmpliPhi Biosciences Corporation (NYSE American: APHB), a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, today announced that the company has received positive feedback, via written response, from the U.S. Food and Drug Administration (FDA) regarding its development plans for AB-PA01, without the need for a Type B Pre-IND meeting.


AmpliPhi Biosciences Announces Positive FDA Feedback for its Clinical Stage Bacteriophage Product Candidate AB-SA01
Posted on Monday September 17, 2018

AmpliPhi Biosciences Corporation (NYSE American: APHB), a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, today announced that the company had a Type B Pre-IND meeting with the U.S. Food and Drug Administration (FDA) and has now received the meeting minutes. Based on the FDA’s feedback, AmpliPhi currently plans to initiate the first randomized clinical trial of its AB-SA01 bacteriophage therapy product candidate in early 2019.


AmpliPhi Biosciences Announces Updated Positive Clinical Results for its Expanded Access Program
Posted on Monday September 17, 2018

AmpliPhi Biosciences Corporation (NYSE American: APHB), a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, today announced updated topline clinical results for its ongoing single-patient expanded access program. 84% of patients achieved treatment success (physician’s assessment) at the end of therapy, defined as complete resolution or significant improvement of baseline signs and symptoms.


Why You Need To Look At This Factor Before Buying AmpliPhi Biosciences Corporation (NYSEMKT:APHB)
Posted on Friday September 07, 2018

Anyone researching AmpliPhi Biosciences Corporation (NYSEMKT:APHB) might want to consider the historical volatility of the share price. Volatility is considered to be a measure of risk in modern finance theory.Read More...


Stock Market & Investing Books

Enter a stock symbol to view the stock details.